Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
European Neurology|January 1, 1997
Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study GroupG Block, C Liss, S Reines, et al.Journal of Psychopharmacology (Oxford, England)|January 1, 1997
Lack of sedative and cognitive effects of diphenhydramine and cyclobenzaprine in elderly volunteersC Lines, M Traub, S Raskin, et al.Journal of Immigrant and Minority Health|February 16, 2017
Adapting an Autism Screening Tool for Use in the DeKalb County Refugee Pediatric ClinicC McClure, S Reines, P S Suchdev, et al.Biological Psychiatry|November 15, 1992
A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorderJ Bradwejn, D Koszycki, L Annable, et al.Neurology|November 1, 1989
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's diseaseJ T Hutton, J L Morris, D F Bush, et al.Headache|May 22, 1998
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study GroupJ Teall, M Tuchman, N Cutler, et al.The American Journal of Cardiology|May 1, 1994
Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemiaM Partinen, S Pihl, T Strandberg, et al.Neurology|November 13, 2008
Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizuresE Faught, G L Holmes, W E Rosenfeld, et al.Biological Psychiatry|April 1, 1995
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorderM S Kramer, N R Cutler, J C Ballenger, et al.Neurology|May 12, 2004
Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraineS Silberstein, S Tepper, J Brandes, et al.Pageof 1